gip receptor tirzepatide gip/glp 1-agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes Frontiers | Tirzepatide against obesity

The researchers said that their analysis shows that tirzepatide is superior to semaglutide for diabetes management and weight loss

Semaglutide has the longer cardiovascular track record Semaglutide's cardiovascular benefit is backed by dedicated outcomes trials SUSTAIN-6, PIONEER-6, and the large SELECT trial that have already reported results

No synthetic FD&C dyes

Your health plan might not cover GLP-1 drugs for weight loss A growing number of employers and insurers wont cover GLP-1s for weight loss, citing concerns about effectiveness, side effects, and cost

Breakouts: In rare cases, individuals with sensitive skin may experience breakouts or acne-like reactions when using glutathione creams